SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Tuesday reported a loss of $20.3 million in its third quarter.
News
- Calithera: 3Q Earnings Snapshot
- Equillium Announces Leadership Updates
His extensive background in strategic biotechnology investments, ... Equillium is a biotechnology company leveraging deep understanding of ... and an M.D. from the University of Texas Health Science Center, San Antonio.
- San Antonio's economy is growing, but faces challenges – a panel discussion
Panelists in the discussion were CEO Rey Chavez from San Antonio Manufactures ... Reed: In the biosciences, I think we've never been better. On the ...
- FibroGen: 3Q Earnings Snapshot
The biotech drug developer posted revenue of $33.2 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks ...
- Global Tangential Flow Filtration (TFF) System Market, Top key players are ALA Scientific ...
... Getinge AB, Harvard Bioscience, Inc., Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.), Livanova PLC, Medtronic PLC .... 1604 W San Antonio,.